X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7607) 7607
Newspaper Article (3049) 3049
Newsletter (271) 271
Magazine Article (193) 193
Book Chapter (57) 57
Trade Publication Article (30) 30
Web Resource (21) 21
Book / eBook (10) 10
Book Review (8) 8
Conference Proceeding (3) 3
Dissertation (3) 3
Publication (2) 2
Reference (2) 2
Journal / eJournal (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
constipation (8002) 8002
humans (5593) 5593
female (3117) 3117
male (2882) 2882
constipation - drug therapy (2227) 2227
middle aged (2055) 2055
adult (1960) 1960
aged (1765) 1765
pain (1758) 1758
irritable bowel syndrome (1739) 1739
clinical trials (1477) 1477
patients (1381) 1381
gastroenterology & hepatology (1325) 1325
pharmaceutical industry (1305) 1305
diarrhea (1276) 1276
treatment outcome (1229) 1229
drug dosages (1108) 1108
constipation - chemically induced (1081) 1081
drug therapy (1059) 1059
care and treatment (1057) 1057
narcotics (907) 907
fda approval (886) 886
constipation - etiology (858) 858
pharmacology & pharmacy (830) 830
laxatives (827) 827
abdomen (788) 788
quality of life (787) 787
double-blind (780) 780
pediatrics (762) 762
research (698) 698
constipation - therapy (689) 689
cancer (688) 688
studies (688) 688
chronic disease (687) 687
adolescent (667) 667
oncology (658) 658
gastroenterology (645) 645
child (643) 643
constipation - physiopathology (624) 624
management (615) 615
cathartics - therapeutic use (598) 598
medicine, general & internal (583) 583
aged, 80 and over (571) 571
animals (570) 570
efficacy (550) 550
double-blind method (532) 532
prevalence (527) 527
analysis (521) 521
cancer therapies (521) 521
analgesics, opioid - adverse effects (517) 517
clinical neurology (512) 512
children (511) 511
medicine & public health (509) 509
quality-of-life (506) 506
medical research (498) 498
surgery (491) 491
chemotherapy (471) 471
irritable-bowel-syndrome (468) 468
nausea (452) 452
safety (452) 452
health aspects (447) 447
laxatives - therapeutic use (443) 443
constipation - diagnosis (434) 434
motility (430) 430
risk factors (421) 421
child, preschool (415) 415
medicine (410) 410
analgesics (406) 406
young adult (383) 383
anemia (378) 378
vomiting (376) 376
colon (374) 374
pain management (366) 366
intestine (364) 364
medicine, experimental (361) 361
gastrointestinal agents (356) 356
diagnosis (351) 351
opioids (351) 351
prospective studies (350) 350
drugs (349) 349
gastrointestinal agents - therapeutic use (349) 349
irritable bowel syndrome - drug therapy (346) 346
abridged index medicus (344) 344
neurosciences (343) 343
metastasis (340) 340
symptoms (335) 335
adults (331) 331
gastrointestinal motility - drug effects (331) 331
internal medicine (317) 317
defecation (316) 316
palliative care (316) 316
infections (314) 314
neutropenia (311) 311
constipation - complications (308) 308
fecal incontinence (305) 305
surveys and questionnaires (305) 305
diabetes (301) 301
dyspnea (301) 301
chronic constipation (300) 300
complications and side effects (300) 300
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10598) 10598
German (261) 261
French (154) 154
Japanese (66) 66
Italian (60) 60
Spanish (58) 58
Chinese (48) 48
Russian (42) 42
Portuguese (20) 20
Danish (19) 19
Polish (17) 17
Dutch (12) 12
Korean (12) 12
Swedish (7) 7
Hungarian (6) 6
Ukrainian (6) 6
Romanian (5) 5
Hebrew (4) 4
Norwegian (4) 4
Bulgarian (3) 3
Finnish (3) 3
Turkish (3) 3
Croatian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 01/2008, Volume 111, Issue 2, pp. 566 - 573
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. e58 - e68
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 06/2018, Volume 2018, Issue 6, p. CD006332
Background Opioid‐induced bowel dysfunction (OIBD) is characterised by constipation, incomplete evacuation, bloating, and gastric reflux. It is one of the... 
Quaternary Ammonium Compounds | Intestinal Diseases | Oxycodone | Receptors, Opioid, mu | Palliative Care | Palliative and supportive care | Naltrexone | Gastrointestinal | 2019 4. Palliative, supportive, frailty | Nalbuphine | Neoplasms | Randomized Controlled Trials as Topic | Narcotic Antagonists | Symptomatic relief | Naloxone | Piperidines | Child health | Opioid‐Related Disorders | Medicine General & Introductory Medical Sciences | Palliative & other supportive care | Constipation | Defecation | Gastrointestinal Agents | Cancer | Piperidines [therapeutic use] | EFFICACY | SAFETY | Humans | GUIDELINES | Gastrointestinal Agents [therapeutic use] | Intestinal Diseases [chemically induced; drug therapy] | MEDICINE, GENERAL & INTERNAL | Receptors | SUBCUTANEOUS METHYLNALTREXONE | Constipation [chemically induced; drug therapy] | PARALLEL-GROUP | Nalbuphine [therapeutic use] | mu [antagonists & inhibitors] | Naloxone [therapeutic use] | INDUCED CONSTIPATION | Opioid-Related Disorders [drug therapy] | Naltrexone [analogs & derivatives; therapeutic use] | Opioid | Quaternary Ammonium Compounds [therapeutic use] | PROLONGED-RELEASE TABLETS | Defecation [drug effects] | PAIN | Narcotic Antagonists [therapeutic use] | DOUBLE-BLIND | ADVANCED ILLNESS | Naltrexone - analogs & derivatives | Naltrexone - therapeutic use | Opioid-Related Disorders - drug therapy | Intestinal Diseases - chemically induced | Male | Neoplasms - complications | Nalbuphine - therapeutic use | Female | Constipation - drug therapy | Oxycodone - adverse effects | Oxycodone - therapeutic use | Defecation - drug effects | Quaternary Ammonium Compounds - therapeutic use | Intestinal Diseases - drug therapy | Narcotic Antagonists - adverse effects | Naloxone - therapeutic use | Receptors, Opioid, mu - antagonists & inhibitors | Constipation - chemically induced | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Naloxone - adverse effects | Gastrointestinal Agents - therapeutic use | Naltrexone - adverse effects
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 2018, Volume 20, Issue 4, pp. 898 - 909
... (BI) among injectable‐drug‐naïve patients with type 2 diabetes mellitus (T2DM) who are elderly or have renal impairment (RI... 
basal insulin | cohort study | exenatide | KIDNEY-DISEASE | PROPENSITY SCORE | CLINICAL-TRIAL | EFFICACY | OLDER-ADULTS | OPEN-LABEL | AMERICAN-HEART-ASSOCIATION | GLOMERULAR-FILTRATION-RATE | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | ONCE-WEEKLY EXENATIDE | Follow-Up Studies | United States | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Diabetic Nephropathies - blood | Young Adult | Injections, Subcutaneous | Aged, 80 and over | Adult | Female | Renal Insufficiency - complications | Renal Insufficiency - drug therapy | Retrospective Studies | Renal Insufficiency - blood | Diabetes Mellitus, Type 2 - complications | Exenatide - adverse effects | Drug Administration Schedule | Insulin - administration & dosage | Treatment Outcome | Blood Glucose - drug effects | Diabetic Nephropathies - complications | Diabetes Mellitus, Type 2 - blood | Adolescent | Exenatide - administration & dosage | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - adverse effects | Renal function | Epidermal growth factor receptors | Diabetes mellitus | Diarrhea | Lipids | Nausea | Hypoglycemia | Electronic medical records | Insulin | Glomerular filtration rate | Vomiting | Hemoglobin | Blood pressure | Diabetes | Diabetes mellitus (non-insulin dependent) | Constipation | Geriatrics | Original
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 7, p. CD010692
... only. Opioid drugs, including oxycodone, are commonly used to treat neuropathic pain, and are considered effective by some professionals... 
Analgesics, Opioid | Delayed‐Action Preparations | Oxycodone | Nausea | Pain & anaesthesia | Management | 2019 3. Chronic pain | Disorders of Excessive Somnolence | Diabetic Neuropathies | Randomized Controlled Trials as Topic | Dizziness | Chronic non‐cancer pain | 2019 3.1 Neuropathic pain | Neuralgia, Postherpetic | Pharmacological therapies | Medicine General & Introductory Medical Sciences | Constipation | TAPENTADOL EXTENDED-RELEASE | Analgesics, Opioid [adverse effects; therapeutic use] | Delayed-Action Preparations [therapeutic use] | Diabetic Neuropathies [drug therapy] | Neuralgia, Postherpetic [drug therapy] | LOW-BACK-PAIN | Humans | CONTROLLED-RELEASE OXYCODONE | RANDOMIZED CONTROLLED-TRIAL | DIABETIC-NEUROPATHY | Fibromyalgia [drug therapy] | Neuralgia [drug therapy] | PHARMACOLOGICAL-TREATMENT | PROLONGED-RELEASE | MEDICINE, GENERAL & INTERNAL | Oxycodone [adverse effects; therapeutic use] | DOUBLE-BLIND | Adult | TRIGEMINAL NEURALGIA | QUALITY-OF-LIFE | Oxycodone - therapeutic use | Disorders of Excessive Somnolence - chemically induced | Nausea - chemically induced | Middle Aged | Dizziness - chemically induced | Constipation - epidemiology | Analgesics, Opioid - therapeutic use | Male | Diabetic Neuropathies - drug therapy | Neuralgia, Postherpetic - drug therapy | Nausea - epidemiology | Constipation - chemically induced | Disorders of Excessive Somnolence - epidemiology | Analgesics, Opioid - adverse effects | Delayed-Action Preparations - therapeutic use | Female | Aged | Oxycodone - adverse effects | Dizziness - epidemiology
Journal Article
Microbiome, ISSN 2049-2618, 2017, Volume 5, Issue 1, p. 10
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 4, pp. 341 - 351
Journal Article
PloS one, ISSN 1932-6203, 2017, Volume 12, Issue 10, p. e0184360
Journal Article